TSC22D1 and PSAP predict clinical outcome of tamoxifen treatment in patients with recurrent breast cancer. - Meijer D; Jansen MP; Look MP; Ruigrok-Ritstier K; van Staveren IL; Sieuwerts AM; van Agthoven T; Foekens JA; Dorssers LC; Berns EM (Breast cancer research and treatment, 2009)